Boston Scientific (NYSE:BSX) acquires privately held nVision Medical, a developer of a device called Mako 7, a microcatheter used to collect cells from the fallopian tube aimed at earlier diagnoses of ovarian cancer.
Under the terms of the deal, Boston will $150M upfront and up to $125M im milestones over the next four years. It says the transaction will be immaterial to non-GAAP results in 2018 and 2019 and accretive thereafter.
MG+M The Law Firm (MG+M) is pleased to announce that it has elevated attorneys Stephanie M. Chesney
Burns & Levinson announced today that well-known plaintiff employment litigator Beth R. Myers has joined the firm
BayCoast Bank is delighted to announce Nicole Almeida as Senior Vice President, Chief Diversity Officer (CDO)
BayCoast Bank is pleased to announce Robert Bergdoll of Attleboro, Massachusetts, as First Vice President Marketing Director
For partnerships, content marketing or advertising inquiries, please contact Edwin through his LinkedIn Profile
Connect© Copyright 2024 citybuzz
